Cargando…
COVID-19 and Alzheimer’s Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future
A growing body of evidence indicates that a neuropathological cross-talk takes place between the coronavirus disease 2019 (COVID-19) -the pandemic severe pneumonia that has had a tremendous impact on the global economy and health since three years after its outbreak in December 2019- and Alzheimer’s...
Autores principales: | Amadoro, Giuseppina, Latina, Valentina, Stigliano, Egidio, Micera, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670749/ https://www.ncbi.nlm.nih.gov/pubmed/37998336 http://dx.doi.org/10.3390/cells12222601 |
Ejemplares similares
-
The Cleavage-Specific Tau 12A12mAb Exerts an Anti-Amyloidogenic Action by Modulating the Endocytic and Bioenergetic Pathways in Alzheimer’s Disease Mouse Model
por: Latina, Valentina, et al.
Publicado: (2023) -
Tau Cleavage Contributes to Cognitive Dysfunction in Strepto-Zotocin-Induced Sporadic Alzheimer’s Disease (sAD) Mouse Model
por: Latina, Valentina, et al.
Publicado: (2021) -
Nerve Growth Factor-Based Therapy in Alzheimer’s Disease and Age-Related Macular Degeneration
por: Amadoro, Giuseppina, et al.
Publicado: (2021) -
Morphological and biomolecular targets in retina and vitreous from Reelin-deficient mice (Reeler): Potential implications for age-related macular degeneration in Alzheimer’s dementia
por: Balzamino, Bijorn Omar, et al.
Publicado: (2022) -
Therapeutic Potential of Targeting Mitochondria for Alzheimer’s Disease Treatment
por: Atlante, Anna, et al.
Publicado: (2022)